Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

NCT01263548 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01263548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01263548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
January 31, 2012
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit/hyperactivity disorder, bipolar disorder